Go to main content

AOP Orphan hosted Industry Symposium at the annual meeting of the German, Austrian and Swiss societies for haematology and medical oncology DGHO on Friday, October 11, 2019.

About AOP Orphan Pharmaceuticals AG:
AOP Orphan is a multinational company with headquarters in Vienna, Austria focusing on clinical development, marketing and distribution of medicines for rare and complex diseases. AOP Orphan provides innovative treatment options, further individualized and customized services to meet physicians and patients needs across Europe, the Middle East & Asia. Currently, AOP Orphan is specializing in therapeutic solutions for HematoOncology, Cardiology & Pulmonology and Neurology & Metabolic Disorders.

To stay updated, follow AOP Orphan on LinkedIn: https://www.linkedin.com/company/aop-orphan-pharmaceuticals/

AOP Orphan Pharmaceuticals AG 
Wilhelminenstrasse 91/IIf, 1160 Vienna, Austria